MA20342A1 - Nouveaux derives de la furo-(3,4-c)pyridine substitues en position 6,ainsi que leur procede de preparation . - Google Patents

Nouveaux derives de la furo-(3,4-c)pyridine substitues en position 6,ainsi que leur procede de preparation .

Info

Publication number
MA20342A1
MA20342A1 MA20566A MA20566A MA20342A1 MA 20342 A1 MA20342 A1 MA 20342A1 MA 20566 A MA20566 A MA 20566A MA 20566 A MA20566 A MA 20566A MA 20342 A1 MA20342 A1 MA 20342A1
Authority
MA
Morocco
Prior art keywords
furo
well
preparation process
new derivatives
pyridine substituted
Prior art date
Application number
MA20566A
Other languages
English (en)
Inventor
Esanu Andre
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of MA20342A1 publication Critical patent/MA20342A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
MA20566A 1984-02-02 1985-02-01 Nouveaux derives de la furo-(3,4-c)pyridine substitues en position 6,ainsi que leur procede de preparation . MA20342A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives

Publications (1)

Publication Number Publication Date
MA20342A1 true MA20342A1 (fr) 1985-10-01

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20566A MA20342A1 (fr) 1984-02-02 1985-02-01 Nouveaux derives de la furo-(3,4-c)pyridine substitues en position 6,ainsi que leur procede de preparation .

Country Status (24)

Country Link
US (1) US4581362A (fr)
JP (1) JPS60181088A (fr)
AT (1) AT391700B (fr)
BE (1) BE901545A (fr)
CA (1) CA1300148C (fr)
CH (1) CH663023A5 (fr)
DE (1) DE3503435A1 (fr)
DK (1) DK158951C (fr)
DZ (1) DZ743A1 (fr)
ES (1) ES8607308A1 (fr)
FI (1) FI82051C (fr)
FR (2) FR2559062B1 (fr)
GB (1) GB8402740D0 (fr)
HK (1) HK92587A (fr)
IE (1) IE58229B1 (fr)
IT (1) IT1200587B (fr)
LU (1) LU85744A1 (fr)
MA (1) MA20342A1 (fr)
NL (1) NL8500241A (fr)
NO (1) NO160369C (fr)
OA (1) OA07947A (fr)
PT (1) PT79913B (fr)
SE (2) SE8500460L (fr)
ZA (1) ZA85508B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
CN104135859B (zh) 2011-12-28 2017-06-27 全球血液疗法公司 取代的苯甲醛化合物及其用于增加组织氧合的方法
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
PE20160078A1 (es) 2013-03-15 2016-03-02 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AP2015008721A0 (en) 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MY183637A (en) 2013-03-15 2021-03-04 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
PT3102208T (pt) 2014-02-07 2021-04-05 Global Blood Therapeutics Inc Polimorfos cristalinos da base livre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3 il)metoxi)benzaldeído
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
TW201731509A (zh) 2015-12-04 2017-09-16 全球血液治療公司 針對２-羥基-６-（（２-（１-異丙基-１ｈ-吡唑-５-基）吡啶-３-基）甲氧基）-苯甲醛之劑量方案
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (fr) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
DK45585A (da) 1985-08-03
FI82051B (fi) 1990-09-28
FI850275A0 (fi) 1985-01-22
NO160369B (no) 1989-01-02
DZ743A1 (fr) 2004-09-13
ATA27585A (de) 1990-05-15
NO160369C (no) 1989-04-12
PT79913A (en) 1985-03-01
ZA85508B (en) 1985-11-27
NL8500241A (nl) 1985-09-02
US4581362A (en) 1986-04-08
JPH0240069B2 (fr) 1990-09-10
DK158951B (da) 1990-08-06
GB8402740D0 (en) 1984-03-07
HK92587A (en) 1987-12-11
FI82051C (fi) 1991-01-10
ES540080A0 (es) 1986-05-16
CA1300148C (fr) 1992-05-05
NO850399L (no) 1985-08-05
SE8500460L (sv) 1985-08-03
FR2559062A1 (fr) 1985-08-09
OA07947A (fr) 1987-01-31
LU85744A1 (fr) 1985-07-24
CH663023A5 (fr) 1987-11-13
FR2559152A1 (fr) 1985-08-09
IE850241L (en) 1985-08-02
IE58229B1 (en) 1993-08-11
DE3503435A1 (de) 1985-08-08
DK45585D0 (da) 1985-02-01
BE901545A (fr) 1985-07-22
DE3503435C2 (fr) 1991-11-07
SE8500460D0 (sv) 1985-02-01
PT79913B (en) 1986-11-10
FR2559062B1 (fr) 1987-05-22
FR2559152B1 (fr) 1987-05-22
IT8519327A0 (it) 1985-02-01
DK158951C (da) 1990-12-31
IT1200587B (it) 1989-01-27
SE460903B (sv) 1989-12-04
JPS60181088A (ja) 1985-09-14
AT391700B (de) 1990-11-12
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03

Similar Documents

Publication Publication Date Title
MA20342A1 (fr) Nouveaux derives de la furo-(3,4-c)pyridine substitues en position 6,ainsi que leur procede de preparation .
FR2554817B1 (fr) Nouveaux derives de la vinyl-6 furo-(3,4-c)-pyridine ainsi que leur procede de preparation
DZ376A1 (fr) Nouveaux dérivés de la furo (3,4-c)-pyridine et leur préparation.
FR2555181B1 (fr) Nouveaux derives de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procede de preparation
RO91871A (fr) Procede pour la preparation des derives de 1,4-dihydro-4-oxonaphtiridine
FR2543956B1 (fr) Derives de la furo-(3,4-c)-pyridine ainsi que leur preparation
FR2571052B1 (fr) Derives de 1,3-oxazolidine-2-one et leur procede de preparation
PT67839B (fr) Procede de preparation de nouveaux derives de la pyrido-/2,3-b/benzothiazepine-(1,5) substitues
FR2566779B2 (fr) Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
FR2553417B1 (fr) Derives de la chloro-4-furo-(3,4-c)-pyridine et leur procede de preparation
FR2572405B1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation
FR2572075B1 (fr) Nouveaux derives de la 4-dioxino-(4,5-c)-pyridine et leur procede de preparation
MA21652A1 (fr) Nouveaux derives de la carbonyl- 2n,n'-di-(trimethoxybenzoyle) piperazine, ainsi que leur procede de preparation .
MA21288A1 (fr) Procede de preparation de nouveaux methoxy-s, alcoyl ammonium tetrahydro-furanes et tetrahydrothiophenes.
MA21499A1 (fr) Procede de preparation de nouveaux derives de la i-arylsylfonyl 2-pyrrolidinone.
ES546136A0 (es) Proceso para producir derivados de 1,4-dihidro-piridina-3,5,dicarboxilato.
FR2563223B1 (fr) Nouveaux derives du pyrane ainsi que leur procede de preparation
MA20517A1 (fr) Nouveaux derives de l'aminomethyle-6 furo-(3,4-c)-pyridine ainsi que leur procede de preparation
BE848627A (fr) Derives substitues d'aminobenzaldehydes et leur procede de preparation,
MA21352A1 (fr) Procede de preparation de nouveaux derives de thieno-imidazole substitues.
FR2569698B1 (fr) Nouveau procede de preparation des derives de la furo-(3,4-c)-pyridine substitues en position 6
BE881764A (fr) NOUVEAUX DERIVES DE LA PYRIDO (3,4-e) -ASTRIAZINE ET PROCEDE DE PREPARATION DE CES DERIVES
FR2564094B1 (fr) Nouveaux derives de la quinoleine ainsi que leur procede de preparation
MA21651A1 (fr) Nouveaux derives de la methoxycarbonyl-2n,n'-di- (trimethoxybenzoyle) piperazine, ainsi que leur procede de preparation .
PT81139A (fr) Procede de preparation de nouveaux derives de (alcoxy-2) phenylpiperaziniques